Clinical trials sponsored by The University of Texas Health Science Center, Houston
36
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 1 2Phase 2 6Phase 4 2Not applicable 26
Conditions studied
Recruiting trials led by The University of Texas Health Science Center, Houston
- A Neurosensory Account of Anxiety and Stress (Study 1)
- A Neurosensory Account of Anxiety and Stress (Study 2)
- Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
- Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression
- Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment
- Application of Virtual Reality Technology to Treatment of Social Anxiety
- Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness
- Behavioral Activation for the PreVention of Post-strokE Depression in LoW-incomE Older Stroke Survivors
- Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia
- Breathing Rescue for SUDEP Prevention
- Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
- De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
- Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple Sclerosis
- Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression
- Diffusion Tensor and Functional Connectivity Imaging in Pediatric Epilepsy: Imaging/Histology Correlation
- EUS-RFA PANCARDINAL-1 Trial
- Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma
- Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
- Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)
- Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis
- Greater Houston Area Pediatric Bipolar Registry
- Improving Adult Protective Services Client Outcomes: A Stepped-Care Social and Mental Health Engagement Program
- Incretin Microdosing for Cardiometabolic Health in People With HIV
- Mapping of Human Cognition
- Multiple Sclerosis Implementation Network (Registry)
- Network Effects of Therapeutic Deep Brain Stimulation
- Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder
- Patient Priorities for Survivorship Care in Older Breast Cancer Survivors
- Pilot Study of Virtual Reality Therapy for Students With Anxiety
- Pre-exposure Prophylaxis (PrEP) Adherence Intervention for Women with Substance Use Disorders
- Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
- Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions
- Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis
- The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis
- The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project
- Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders
Common questions
How many trials is The University of Texas Health Science Center, Houston recruiting for?
The University of Texas Health Science Center, Houston is the lead sponsor of 36 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.